Dilated Cardiomyopathies of the Adult

New England Journal of Medicine

Volumn 307, Issue 17, 1982, Pages 1051-1058

  Johnson, Robert Arnold ^a   Palacios, Igor ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; HEART; REVIEW;

ALCOHOLISM; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HEART VALVE DISEASES; HUMAN; MYOCARDIAL DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS;

EID: 0019993744     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198210213071704     Document Type: Review

References (109)

1. Goodwin J.F., Oakley C.M. The cardiomyopathies. Br Heart J. 1972; 34:545-552
2. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J. 1980; 44:672-673
3. Roberts W.C., Ferrans V.J. Pathologic anatomy of the cardiomyopathies: idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia. Hum Pathol. 1975; 6:287-342.
4. Maron B.J., Epstein S.E. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol. 1979; 43:1242-1244
5. Perloff J.K. The cardiomyopathies — current perspectives. Circulation. 1971; 44:942-949
6. Navarro-Lopez F., Llorian A., Ferrer-Roca O., Betriu A., Sanz G. Restrictive cardiomyopathy in pseudoxanthoma elasticum. Chest. 1980; 78:113-115
7. Benotti J.R., Grossman W., Cohn P.F. Clinical profile of restrictive cardiomyopathy. Circulation. 1980; 61:1206-1212
8. Waller B.F., Gottdiener J.S., Virmani R., Roberts W.C. The “charcoal heart”: melanoma to the cor. Chest. 1980; 77:671-676
9. James C.F., Hutchins G.M. Congestive heart failure secondary to diffuse organized biventricular mural thrombus following mitral valve replacement. Chest. 1980; 78:338-340
10. Ali M., Fayemi A.O., Malcolm D., Braun E.V. Intraventricular thrombosis in polycythemia vera: a cause of intractable cardiac failure. Am Heart J. 1980; 100:520-522
11. Tavel M.E., Petrin T.E. Hypertrophic subaortic stenosis in the “real world.” Chest. 1980; 77:715-718
12. Bloom K.R., Meyer R.A., Bove K.E., Kaplan S. The association of fixed and dynamic left ventricular outflow obstruction. Am Heart J. 1975; 89:586-590
13. Elliott C.M., Tajik A.J., Giuliani E.R., Gordon H. Idiopathic hypertrophic subaortic stenosis associated with cutaneous neurofibromatosis: report of a case. Am Heart J. 1976; 92:368-372
14. Gutgesell H.P., Speer M.E., Rosenberg H.S. Characterization of the cardiomyopathy in infants of diabetic mothers. Circulation. 1980; 61:441-450
15. Bell R., Barber P.V., Bray C.L., Beton D.C. Incidence of thyroid disease in cases of hypertrophic cardiomyopathy. Br Heart J. 1978; 40:1306-1309
16. Santos A.D., Miller R.P., Mathew P.K., Wallace W.A., Cave W.T. Jr., Hinojosa L. Echocardiographic characterization of the reversible cardiomyopathy of hypothyroidism. Am J Med. 1980; 68:675-682
17. Johnson R.A. Heart failure. In: Johnson RA, Haber E, Austen WG, eds. The practice of cardiology. Boston: Little, Brown, 1980: 31-95.
18. Alexander J., Dainiak N., Berger H.J., et al. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med. 1979; 300:278-283
19. Feild B.J., Baxley W.A., Russell R.O. Jr., et al. Left ventricular function and hypertrophy in cardiomyopathy with depressed ejection fraction. Circulation. 1973; 47:1022-1031
20. Dodge H.T., Baxley W.A. Hemodynamic aspects of heart failure. Am J Cardiol. 1968; 22:24-34.
21. Sharma B., Goodwin J.F. Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy: effect on systolic and diastolic function of the left ventricle. Circulation. 1978; 58:449-460
22. Engler R., Ray R., Higgins C.B., et al. Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopathy. Am J Cardiol. 1982; 49:1832-1837
23. Harvey W.P., Segal J.P., Gurel T. The clinical spectrum of primary myocardial disease. Prog Cardiovasc Dis. 1964; 7:17-42.
24. Cutler D.J., Isner J.M., Bracey A.W., et al. Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy. Am J Med. 1980; 69:923-928
25. Bolen J.L., Alderman E.L. Ventriculographic and hemodynamic features of mitral regurgitation of cardiomyopathic, rheumatic and nonrheumatic etiology. Am J Cardiol. 1977; 39:177-183
26. Johnson R.A., Palacios I. Dilated cardiomyopathy and nonhypertrophic nondilated cardiomyopathy. In: Johnson RA, Haber E, Austen WG, eds. The practice of cardiology. Boston: Little, Brown, 1980: 603-46.
27. Fowler N.O., Gueron M. Primary myocardial disease. Circulation. 1965; 32:830-836
28. Olsen E.G.J. The pathology of cardiomyopathies: a critical analysis. Am Heart J. 1979; 98:385-392
29. Maron B.J., Roberts W.C. Cardiomyopathies in the first two decades of life. Cardiovasc Clin. 1981; 11(2):35-78.
30. Baandrup U., Florio R.A., Roters F., Olsen E.G.J. Electron microscopic investigation of endomyocardial biopsy samples in hypertrophy and cardiomyopathy. Circulation. 1981; 63:1289-1298
31. Baandrup U., Florio R.A., Rehahn M., Richardson P.J., Olsen E.G.J. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. II. Comparison of histology and clinical/haemodynamic information. Br Heart J. 1981; 45:487-493
32. Connor D.H., Somers K., Hutt M.S.R., Manion W.C., D#x0027;Arbela P.G. Endomyocardial fibrosis in Uganda (Davies#x0027; disease). I. An epidemiologic, clinical, and pathologic study. Am Heart J. 1967; 74:687-709.
33. Seftel H.C., Metz J., Lakier J.B. Aetiology of cardiomyopathy in Johannesburg Africans. In: Bajusz E, Rona G, Brink AJ, Lochner A, eds. Recent advances in studies on cardiac structure and metabolism. Vol. 2. Cardiomyopathies. Baltimore: University Park Press, 1973: 165-80.
34. Hill K.R., Still W.J.S., McKinney B. Jamaican cardiomyopathy. Br Heart J. 1967; 29:594-601.
35. Gillanders A.D. nutritional heart disease. Br Heart J. 1951; 13:177-196
36. Keshan Disease Research Group of the Chinese Academy of Medical Sciences, Beijing; Antiepidemic Station of Sichuan Province, Chengdu; Antiepidemic Station of Xichang District, Sichuan; Antiepidemic Station of Mianning County, Sichuan. Observations on effect of sodium selenite in prevention of Keshan disease. Chin Med J [Engl]. 1979; 92:471-476
37. Keshan Disease Research Group of the Chinese Academy of Medical Sciences, Beijing. Epidemiologic studies on the etiologic relationship of selenium and Keshan disease. Chin Med J [Engl]. 1979; 72:477-482
38. Johnson R.A., Baker S.S., Fallon J.T., et al. An Occidental case of cardiomyopathy and selenium deficiency. N Engl J Med. 1981; 304:1210-1212
39. Anselmi A., Suarez J.A., Anselmi G., Moleiro F., de Saurez C., Ruesta V. Primary cardiomyopathy in identical twins. Am J Cardiol. 1975; 35:97-102.
40. Ross R.S., Bulkley B.H., Hutchins G.M., et al. Idiopathic familial myocardiopathy in three generations: a clinical and pathologic study. Am Heart J. 1978; 96:170-179
41. Smith W.G. Coxsackie B myopericarditis in adults. Am Heart J. 1970; 80:34-46.
42. Sainani G.S., Krompotic E., Slodki S.J. Adult heart disease due to the coxsackie virus B infection. Medicine (Baltimore). 1968; 47:133-147
43. Arribada A., Thiermann E. Contribution to diagnostic problem of cardiomyopathies produced by Toxoplasma gondii. In: Bajusz E, Rona G, Brink AJ, Lochner A, eds. Recent advances in studies on cardiac structure and metabolism. Vol. 2. Cardiomyopathies. Baltimore: University Park Press, 1973: 655-68.
44. Obeyesekere I., Hermon Y. Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever — a follow-up study. Am Heart J. 1973; 85:186-194
45. Oda T., Hamamoto K., Morinaga H. Sequelae of nonrheumatic myocarditis in children: a follow-up study. Jpn Circ J. 1980; 44:817-822
46. Cambridge G., MacArthur C.G.C., Waterson A.P., Goodwin J.F., Oakley C.M. Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J. 1979; 41:692-696
47. El-Hagrassy M.M.D., Banatvala J.E., Coltart D.J. Coxsackie-B-virus–specific IgM responses in patients with cardiac and other diseases. Lancet. 1980; 2:1160-1162
48. Fuster V., Gersh B.J., Giuliani E.R., Tajik A.J., Brandenburg R.O., Frye R.L. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981; 47:525-531
49. Virus, immunology and the heart. Lancet. 1979; 2:1111-1113
50. Darsee J.R., Nutter D.O., Hopkins L.C. Jr., Heymsfield S.B. Neurogenic skeletal myopathy in patients with primary cardiomyopathy. Circulation. 1979; 59:492-497
51. Fowles R.E., Bieber C.P., Stinson E.B. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation. 1979; 59:483-491
52. Trueman T., Thompson R.A., Cummins P., Littler W.A. Heart antibodies in cardiomyopathies. Br Heart J. 1981; 46:296-301.
53. Dickinson J. (chairman). Debate: That congestive cardiomyopathy is really hypertensive heart disease in disguise. Postgrad Med J. 1972; 48:777-89 (remarks of I. F. Brockington).
54. Oakley C.M. Clinical recognition of the cardiomyopathies. Circ Res. 1974; 35: Suppl:152-167
55. Dickinson J. (chairman). Debate: That congestive cardiomyopathy is really hypertensive heart disease in disguise. Postgrad Med J. 1972; 48:777-89 (remarks of J. F. Goodwin).
56. Abelmann W.H. The cardiomyopathies. Hosp Pract. 1971; 6(3):101-112
57. Goodwin J.F. Prospects and predictions for the cardiomyopathies. Circulation. 1974; 50:210-219
58. Desa#x0027;Neto A., Bullington J.D., Bullington R.H., Desser K.B., Benchimol A. Coxsackie B5 heart disease: demonstration of inferolateral wall myocardial necrosis. Am J Med. 1980; 68:295-298
59. Convert G., Delaye J., Beaune J., Biron A., Gonin A. Étude prognostique des myocardiopathies primitives non obstructives. Arch Mal Coeur. 1980; 3:227-237
60. Marriott H.J.L. Electrocardiographic abnormalities, conduction disorders and arrhythmias in primary myocardial disease. Prog Cardiovasc Dis. 1964; 7:99-114.
61. Probst P., Pachinger O., Murad A.A., Leisch F., Kaindl F. The HQ time in congestive cardiomyopathies. Am Heart J. 1979; 97:436-441
62. Gau G.T., Goodwin J.F., Oakley C.M., et al. Q-waves and coronary arteriography in cardiomyopathy. Br Heart J. 1972; 34:1034-1041
63. Follansbee W.P., Michelson E.L., Morganroth J. Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death. Ann Intern Med. 1980; 92:741-747
64. Shirey E.K., Proudfit W.L., Hawk W.A. Primary myocardial disease: correlation with clinical findings, angiographic and biopsy diagnosis. Am Heart J. 1980; 99:198-207.
65. Benjamin I.J., Schuster E.H., Bulkley B.H. Cardiac hypertrophy in idiopathic dilated congestive cardiomyopathy: a clinicopathologic study. Circulation. 1981; 64:442-447
66. Lee D.C.-S., Johnson R.A., Bingham J.B., et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med. 1982; 306:699-705.
67. Arnold S.B., Byrd R.C., Meister W., et al. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med. 1980; 303:1443-1448
68. Packer M., Le Jemtel T.H. Physiologic and pharmacologic determinants of vasodilator response: a conceptual framework for rational drug therapy for chronic heart failure. Prog Cardiovasc Dis. 1982; 24:275-292
69. Franciosa J.A. Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure. Prog Cardiovasc Dis. 1982; 24:319-330
70. Maskin C.S., Forman R., Klein N.A., Sonnenblick E.H., Le Jemtel T.H. Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of the disease. Am J Med. 1982; 72:113-118
71. Waagstein F., Reiz S., Ariniego R., Hjalmarson A. Clinical results with prenalterol in patients with heart failure. Am Heart J. 1981; 102:548-554
72. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 1980; 44:117-133
73. Ikram H., Fitzpatrick D. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy. Lancet. 1981; 2:490-493
74. Burch G.E., Giles T.D. Management of cardiomyopathy with bed rest. In: Bajusz E, Rona G, Brink AJ, Lochner A, eds. Recent advances in studies on cardiac structure and metabolism. Vol. 2. Cardiomyopathies. Baltimore: University Park Press, 1973: 783-95.
75. Podrid P.J., Schoeneberger A., Lown B. Congestive heart failure caused by oral disopyramide. N Engl J Med. 1980; 302:614-617
76. Ruskin J.N., DiMarco J.P., Garan H. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med. 1980; 303:607-613
77. Hassell L.A., Fowles R.E., Stinson E.B. Patients with congestive cardiomyopathy as cardiac transplant recipients. Am J Cardiol. 1981; 47:1205-1209
78. Jamieson S.W., Oyer P.E., Reitz B.A., et al. Cardiac transplantation at Stanford. Heart Transplant. 1982; 1:86-91.
79. Phillips H.R., Levine F.H., Carter J.E., et al. Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. Am J Cardiol. 1981; 48:647-654
80. Demakis J.G., Proskey A., Rahimtoola S.H., Sutton G.C., Gunnar R.M., Tobin J.R. The natural course of alcoholic cardiomyopathy. Ann Intern Med. 1974; 80:293-297
81. Alexander C.S. Idiopathic heart disease. I. Analysis of 100 cases with special reference to chronic alcoholism. Am J Med. 1966; 41:213-228
82. Schwartz L., Sample K.A., Wigle E.D. Severe alcoholic cardiomyopathy reversed with abstention from alcohol. Am J Cardiol. 1975; 36:963-966
83. Zambrano S.S., Mazzotta J.F., Sherman D., Spodick D.H. Cardiac dysfunction in unselected chronic alcoholic patients: noninvasive screening by systolic time intervals. Am Heart J. 1974; 87:318-320
84. Rubin E. Alcoholic myopathy in heart and skeletal muscle. N Engl J Med. 1979; 301:28-33.
85. Evans W. Alcoholic myocardiopathy. Prog Cardiovasc Dis. 1964; 7:151-171
86. Bing R.J. Cardiac metabolism: its contributions to alcoholic heart disease and myocardial failure. Circulation. 1978; 58:965-970
87. Child J.S., Kovick R.B., Levisman J.A., Pearce M.L. Cardiac effects of acute ethanol ingestion unmasked by autonomic blockade. Circulation. 1979; 59:120-125
88. Regan T.J., Haider B. Ethanol abuse and heart disease. Circulation. 1981; 64: Suppl 3:III-14-9.
89. Greenspon A.J., Stang J.M., Lewis R.P., Schaal S.F. Provocation of ventricular tachycardia after consumption of alcohol. N Engl J Med. 1979; 301:1049-1050
90. Seneviratne B.I.B. Acute cardiomyopathy with rhabdomyolysis in chronic alcoholism. Br Med J. 1975; 4:378-380
91. Alexander C.S. Cobalt and the heart. Ann Intern Med. 1969; 70:411-413
92. Walsh J.J., Burch G.E., Black W.C., Ferrans V.J., Hibbs R.G. Idiopathic myocardiopathy of the puerperium (postpartal heart disease). Circulation. 1965; 32:19-31.
93. Demakis J.G., Rahimtoola S.H., Sutton G.C., et al. Natural course of peripartum cardiomyopathy. Circulation. 1971; 44:1053-1061
94. McD Davidson N., Parry E.H.O. Peripartum cardiac failure. In: Shaper AG, Hutt MSR, Fejfar Z, eds. Cardiovascular disease in the tropics. London: British Medical Association, 1974: 199-208.
95. Fillmore S.J., Parry E.H.O. The evolution of peripartal heart failure in Zaria, Nigeria: some etiologic factors. Circulation. 1977; 56:1058-1061
96. Sanderson J.E., Adesanya C.O., Anjorin F.I., Parry E.H.O. Postpartum cardiac failure — heart failure due to volume overload? Am Heart J. 1979; 97:613-621
97. Dash H., Johnson R.A., Dinsmore E., Harthorne J.W. Cardiomyopathic syndrome due to coronary artery disease. I. Relation to angiographic extent of coronary disease and to remote myocardial infarction. Br Heart J. 1977; 39:733-739
98. Johnson R.A., Daggett W.M. Jr. Heart failure resulting from coronary artery disease. In: Johnson RA, Haber E, Austen WC, eds. The practice of cardiology. Boston: Little, Brown, 1980: 339-69.
99. Manley J.C., King J.F., Zeft H.J., Johnson W.D. The “bad” left ventricle: results of coronary surgery and effect on late survival. J Thorac Cardiovasc Surg. 1976; 72:841-848
100. Yatteau R.F., Peter P.H., Behar V.S., Bartel A.G., Rosati R.A., Kong Y. Ischemic cardiomyopathy: the myopathy of coronary artery disease: natural history and results of medical versus surgical treatment. Am J Cardiol. 1974; 34:520-525
101. Dash H., Johnson R.A., Dinsmore R.E., Francis C.K., Harthorne J.W. Cardiomyopathic syndrome due to coronary artery disease. II. Increased prevalence in patients with diabetes mellitus: a matched pair analysis. Br Heart J. 1977; 39:740-747
102. Phillips H.R., Johnson R.A., Hindman M.A., et al. Aortocoronary bypass grafting in patients without left main stenosis: relation of risk factors to early and late survival. Br Heart J. 1981; 45:549-554
103. Radford M.J., Johnson R.A., Buckley M.J., Daggett W.M., Leinbach R.C., Gold H.K. Survival following mitral valve replacement for mitral regurgitation due to coronary artery disease. Circulation. 1979; 60: Suppl 1:1-39–47.
104. Schlant R.C., Nutter D.O. Heart failure in valvular heart disease. Medicine (Baltimore). 1971; 50:421-451
105. Ross J. Jr. Left ventricular function and the timing of surgical treatment in valvular heart disease. Ann Intern Med. 1981; 94:498-504.
106. Henry W.L., Bonow R.O., Rosing D.R., Epstein S.E. Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. Circulation. 1980; 61:484-492
107. Boucher C.A., Bingham J.B., Osbakken M.D., et al. Early changes in left ventricular size and function after correction of left ventricular volume overload. Am J Cardiol. 1981; 47:991-1004.
108. O#x0027;Rourke R.A., Crawford M.H. Timing of valve replacement in patients with aortic regurgitation. Circulation. 1980; 61:493-495
109. Carabello B.A., Green L.H., Grossman W., Cohn L.H., Koster J.K., Collins J.J. Jr. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation. 1980; 62:42-48